ProfileGDS5822 / ILMN_3050451
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 51% 50% 43% 26% 50% 6% 34% 43% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 122.151
GSM1276600PDAC Late Ablation Control 224.450
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 11743
GSM1276603PDAC Late Ablation 213.826
GSM1276604PDAC Late Ablation 324.250
GSM1303940PDAC Late Ablation_anti-CTLA4 17.56
GSM1303941PDAC Late Ablation_anti-CTLA4 216.434
GSM1303942PDAC Late Ablation_anti-CTLA4 320.943